Clearside Biomedical Inc Clsd Ceo Daniel White On Q3 2018 Results Earnings Call Transcript | Latest News RSS feed

Clearside Biomedical Inc Clsd Ceo Daniel White On Q3 2018 Results Earnings Call Transcript - Latest News


Clearside Biomedical Inc. (CLSD) CEO Daniel White on Q3 2018 Results - Earnings Call Transcript

Clearside Biomedical Inc. (NASDAQ:CLSD) Q3 2018 Results Earnings Conference Call November 8, 2018 8:30 AM ET Executives Brion Raymond - Chief Commercial Officer Charles Deignan - CFO & Secretary ... read more

Clearside Biomedical to Participate in 2018 Janney Healthcare Conference

10, 2018 ... Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, announced today th... read more

Why Positive Results Just Aren’t Good Enough for Clearside Bio

Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on ... compared to 73% in the control. Daniel White, Clearside’s CEO and president, commented: We are pleased with the topline results of ... read more

Looking for another news?


Clearside Biomedical (CLSD) CEO Daniel White on Q3 2017 Results - Earnings Call Transcript

Clearside Biomedical (NASDAQ:CLSD) Q3 2017 Results Earnings Conference Call November 8, 2017 9:00 AM ET Executives Stephen Kilmer - IR Daniel White - CEO Richard Beckman - Chief ... the trial in the f... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us